Also called: Insulin Like Growth Factor 1 Protein
IGF-1 stands for insulin-like growth factor 1. It is a small protein made of 70 building blocks called amino acids. Your body makes most of it in the liver. It helps children grow and helps adults keep and build muscle, bone, and cartilage. IGF-1 works like a growth messenger.
It tells cells to grow, multiply, and survive. It is shaped a lot like insulin, the blood sugar hormone, so the two can affect each other's jobs. Doctors use a lab-made copy of IGF-1, called mecasermin, to help children who are not growing well. Lower IGF-1 levels have been linked to having too much body fat. Scientists are still learning about IGF-1.
Some clinic websites say it may help with weight loss, metabolism, and insulin problems, but strong proof in people is limited. Side effects like swelling have caused people to drop out of studies. IGF-1 is a strong growth signal, so it should only be used under a doctor's care. People with some cancers may need to be careful, because it can make cells grow.
Benefits
The main themes across 34 research studies, in plain language.
Research suggests IGF-1 plays a central role in stimulating muscle cell proliferation, enhancing protein synthesis, and increasing muscle mass.
Evidence suggests IGF-1 helps maintain bone mineral density and supports the health of skeletal tissues.
IGF-1 is identified as a key mediator of growth hormone effects, supporting linear bone growth and overall development in children.
Observational studies in Laron syndrome suggest unique IGF-1 profiles may be associated with resistance to cancer and diabetes.
Formulation research focuses on extending the active half-life of IGF-1 and reducing binding to inhibitory proteins to improve bioavailability.
Research indicates that specific formulation methods, such as lyophilization, can preserve the structural integrity and bioactivity of peptides.
Research suggests IGF-1 facilitates cellular growth, angiogenesis, and the repair of various tissues, including skin and internal organs.
Studies suggest IGF-1 may support the assembly of neural networks in the gut and the maintenance of the enteric nervous system.
Evidence suggests IGF-1 is present in colostrum and may contribute to early immunological health outcomes in infants.
Research indicates IGF-1 activates critical pathways (such as PI3K/Akt) that regulate cell survival, growth, and apoptosis.
Research suggests IGF-1 influences nutrient partitioning, potentially promoting lean mass accretion and supporting fat metabolism.
Studies indicate IGF-1 helps regulate fat metabolism, supports insulin sensitivity, and is associated with a lower risk of metabolic abnormalities.
Research points to potential cardioprotective effects and roles in plaque stabilization within blood vessels.
Evidence points to neuroprotective properties that may support neuronal survival, cognitive health, and delay the progression of conditions like ALS.
Studies suggest potential benefits for improving stamina, accelerating recovery from training, and reducing muscle fatigue.
You just read the research on IGF-1. The cheat-sheet maps the most-used peptide stacks — doses, timing, and what to check before buying — on one page.
No spam. Unsubscribe anytime.
1 reported routine — each line links to the source it came from.
From published sources
Routines as reported in peer-reviewed papers, clinical guidance, or vetted media — each linked to the source it came from.
SubQ
mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.
Safety
Adverse effects reported in the research and by community use.
Reported in research and community sources — not exhaustive. Discontinue use and consult a healthcare professional if side effects occur.
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
Evidence
Every claim above traces back to a source you can check — here are 12 of them.
Mechano growth factor, a splice variant of IGF-1, promotes neurogenesis in the aging mouse brain.
Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant.
The nutritional quality of an infant food from quinoa and its effect on the plasma level of insulin-like growth factor-1 (IGF-1) in undernourished children.
IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype.
Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy.
Figure - Overview of the cardiovascular effects of the GH/IGF-1 axis
Antisense Oligonucleotide-Mediated Downregulation of IGFBPs Enhances IGF-1 Signaling.
IGF-1R Antagonism in Thyroid Eye Disease and Female Reproductive Function.
Nutrition, GH/IGF-1 signaling, and cancer
Higher circulating levels of IGF-1 are associated with longer leukocyte telomere length in healthy subjects
Higher plasma IGF-1 levels are associated with increased delta sleep in healthy older men
Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population
Timeline
Key moments in IGF-1’s research and regulatory timeline — sourced and dated.
News
Dated, sourced reporting that mentions IGF-1.
The review examines IGF-1's role in the aging brain, Alzheimer's disease pathology, neuroinflammation, and cognition. It surveys evidence that elevated serum IGF-I levels have been linked to better cognition and overall brain health. It also cites findings that higher baseline IGF-1 levels were linked to better performance on executive function tasks in Alzheimer's patients.
Eton Pharmaceuticals completed its asset acquisition of Increlex (mecasermin injection) from Ipsen S.A. on December 19, 2024, paying $22.5 million at closing plus $8.7 million for product inventory. The filing states Increlex is a biologic used to treat children and adolescents from 2 to 18 years old with severe primary insulin-like growth factor 1 deficiency (SPIGFD). Eton also expanded its SWK Holdings credit facility to $30 million as part of the transaction.
Wondering how IGF-1 pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →Explore by goal
Related peptides
Compare
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.